Home | Welcome to Contract Pharma   
Last Updated Wednesday, July 23 2014
Print

Trials & Filings in Brief: Nov. 7, 2013



By Gil Roth



Published November 7, 2013
Phase I
Omeros TMA treatment well tolerated . . . read more

Phase II
Agenus posts good herpes vax results . . . read more

NovaBay impetigo treatment misses endpoint . . . read more

Phase III
Celgene to present Revlimid data at ASH . . . read more

Gazyva wallops Rituxan in CLL trial . . . read more

Filings
Bayer files for DME indication for Eylea . . . read more


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On